BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 22, 2019
View Archived Issues
Flesh-eating bacteria definitely not better together
Read More
BRN4/BRN2 TFs released in prostate cancer-derived EVs drive neuroendocrine differentiation in NEPC
Read More
AbbVie constructs anti-TNF-alpha antibody-steroid antibody-drug conjugate for rheumatoid arthritis
Read More
Pfizer presents early clinical data for PF-06865571 and PF-05221304
Read More
Phase I data reported for DNA vaccine GLS-6150 in patients with chronic HCV infection
Read More
Recessive mutations in BSN identified as potential new cause of SRNS
Read More
Osteoclast precursor macrophages are potential RA therapeutic targets
Read More
European Commission approves Rhokiinsa
Read More
FDA clears IND application for phase I study of BP-1002
Read More
First-in-human study of AZD-2693
Read More
Pfizer initiates first-in-human study of PF-07038124
Read More
Positive preclinical data reported for leronlimab in humanized mouse model of NAFLD
Read More
ALG-055009: a THR-beta agonist for treating NASH
Read More
Phase II data on AG-10 in ATTR cardiomyopathy support entry into phase III
Read More
First-in-human trial with the triple gene construct INXN-4001 for treatment of heart failure
Read More
CtBP2 affects multiple pathways in acute kidney injury
Read More
New cannabinoid receptor modulators revealed in recent patent
Read More
University of Texas System discloses PTPN11 inhibitors
Read More
Incyte discloses adenosine A2A and A2B receptor antagonists
Read More
Chinese researchers identify BRD4 inhibitors
Read More
New compounds for cancer patented by Hinova Pharmaceuticals
Read More
FDA approves Calquence for CLL and SLL
Read More
Xcopri wins FDA approval for partial-onset seizures in adults
Read More
Aprinoia begins phase II study of tau PET tracer 18F-APN-1607
Read More
Inhibiting bradykinin B1 receptor may alleviate hypertensive kidney disease
Read More